4.35
8.03%
-0.38
전일 마감가:
$4.73
열려 있는:
$4.5328
하루 거래량:
13,713
Relative Volume:
0.36
시가총액:
$205.17M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Company Profile
명칭
Zhengye Biotechnology Holding Ltd
전화
-
주소
-
ZYBT을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
ZYBT
Zhengye Biotechnology Holding Ltd
|
4.35 | 205.17M | 0 | 0 | 0 | 0.00 |
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Zhengye Biotechnology Holding Ltd 주식(ZYBT)의 최신 뉴스
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising - Bamboo Works
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option - GlobeNewswire
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - The Manila Times
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewswire
ZYBT IPO NewsChinese animal health company Zhengye Biotechnology prices US IPO at the $4 low end - Renaissance Capital
Chinese vaccine maker Zhengye Biotechnology prices IPO at $4 per share - MSN
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewswire
Zhengye Biotechnology Holding Limited (ZYBT) to Raise $7 Million in IPO - Defense World
Chinese animal health company Zhengye Biotechnology ups share offering by 20% ahead of $7 million US IPO - Renaissance Capital
Zhengye Biotechnology Holding Ltd (ZYBT) 재무 분석
Zhengye Biotechnology Holding Ltd (ZYBT)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):